维普期刊资源整合服务平台（V6.5）

176篇 您的检索式：作者名="Olsson GG"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	The case for intensive statin therapy aider acute coronary syndromes 显示文摘	Schwartz GG Olsson AG	2005	Am J Cardiol2005，96，5：	1
2	High-density lipopro- tein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome:results from the MIRACL trial显示文摘	Olsson AG Schwartz GG Szarek M	2005	Eur Heart J2005，26，9：	1
3	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，：	1
4	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial显示文摘	Olsson AG Ezekowitz MD	2001	JAMA2001，285，：	1
5	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，13：	1
6	Effects of high-dose atorvas-tatin in patients≥65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering study)显示文摘	Olsson AG Schwartz GG Szarek M et a1	2007	Am JCaMiol2007，99，5：	1
7	Biological mechanis for the clinical success of lipid-lowering in coronary arthry disease and the use of surrogate endpoints显示文摘	kinlay S Schwartz GG Olsson AG	1996	Curr Opin Lipidol1996，7，：	1
8	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes the MIRACL study:a randomizedcontrolled trial显示文摘	Schwartz GG Olsson Ag Ezekowitz MD	2001	JAMA2001，285，：	1
9	lnflammatory bio- markers,death,and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study显示文摘	Zamani P Schwartz GG Olsson AG	2013	J Am Heart Assoc2013，282，00：	1
10	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz Md	2001	JAMA2001，285，13：	1
11	High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study 显示文摘	Kinlay S Schwartz GG Olsson AG	2003	Circulation2003，108，13：	1
12	Effects of atorvastatin on early recurrent ischemia events in acute coronary syndrome,the MIRACL study,A randomised clinical trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，3：	1
13	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，13：	1
14	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，13：	1
15	Biological mechanism for the clinical success of lipid-lowering in coronary arthry diseaes and the use of surrogate endpoints显示文摘	KINLAY S SCHWARTZ GG OLSSON AG	1996	Curr Opin Lipidol1996，7，4：	1
16	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial显示文摘	Olsson AG Ezekowitz MD	2001	JAMA2001，285，：	1
17	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes the MIRACL study:a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，13：	1
18	Effects of atorvastatin on early recurrent ischemic events in acute cyndromes; the MIRACL study: a randomized controlled trial 显示文摘	Schwartz GG Olsson Ag Ezekowitz MD	2001	JAMA2001，285，：	1
19	High-dose atorvastatin enhances the decline in inflammatory markers inpatients with acute coronary syndromes in the MIRACL study显示文摘	Kinlay S Schwartz GG Olsson AG	2003	Circulation2003，108，13：	1
20	Inflammation,statin therapy,and risk of stroke after an acute coronary syndrome in the MIRACL study显示文摘	Kinlay S Schwartz GG Olsson AG		0，，01：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示